Zelek WM - Search Results

1

Mechanism and intervention of murine transfusion-related acute lung injury caused by anti-CD36 antibodies.

Chen DW, Kang T, Xu XZ, Xia WJ, Ye X, Wu YB, Xu YR, Liu J, Ren H, Deng J, Chen YK, Ding HQ, Aslam M, Zelek WM, Morgan BP, Kapur R, Santoso S, Fu YS. Chen DW, et al. Among authors: zelek wm. JCI Insight. 2023 Mar 22;8(6):e165142. doi: 10.1172/jci.insight.165142. JCI Insight. 2023. PMID: 36809299 Free PMC article.

2

Absence of CD59 in Guinea Pigs: Analysis of the Cavia porcellus Genome Suggests the Evolution of a CD59 Pseudogene.

Boshra H, Zelek WM, Hughes TR, Rodriguez de Cordoba S, Morgan BP. Boshra H, et al. Among authors: zelek wm. J Immunol. 2018 Jan 1;200(1):327-335. doi: 10.4049/jimmunol.1701238. Epub 2017 Nov 22. J Immunol. 2018. PMID: 29167230 Free PMC article.

3

Characterizing a pH-switch anti-C5 antibody as a tool for human and mouse complement C5 purification and cross-species inhibition of classical and reactive lysis.

Zelek WM, Stott M, Walters D, Harris CL, Morgan BP. Zelek WM, et al. Immunology. 2018 Nov;155(3):396-403. doi: 10.1111/imm.12982. Epub 2018 Jul 30. Immunology. 2018. PMID: 29981529 Free PMC article.

4

Extracting the barbs from complement assays: Identification and optimisation of a safe substitute for traditional buffers.

Zelek WM, Harris CL, Morgan BP. Zelek WM, et al. Immunobiology. 2018 Dec;223(12):744-749. doi: 10.1016/j.imbio.2018.07.016. Epub 2018 Jul 20. Immunobiology. 2018. PMID: 30033110

5

Development and characterization of novel anti-C5 monoclonal antibodies capable of inhibiting complement in multiple species.

Zelek WM, Taylor PR, Morgan BP. Zelek WM, et al. Immunology. 2019 Aug;157(4):283-295. doi: 10.1111/imm.13083. Epub 2019 Jun 17. Immunology. 2019. PMID: 31120547 Free PMC article.

6

Compendium of current complement therapeutics.

Zelek WM, Xie L, Morgan BP, Harris CL. Zelek WM, et al. Mol Immunol. 2019 Oct;114:341-352. doi: 10.1016/j.molimm.2019.07.030. Epub 2019 Aug 22. Mol Immunol. 2019. PMID: 31446305 Free article. Review.

7

Cerebrospinal fluid complement system biomarkers in demyelinating disease.

Zelek WM, Fathalla D, Morgan A, Touchard S, Loveless S, Tallantyre E, Robertson NP, Morgan BP. Zelek WM, et al. Mult Scler. 2020 Dec;26(14):1929-1937. doi: 10.1177/1352458519887905. Epub 2019 Nov 8. Mult Scler. 2020. PMID: 31701790

8

Characterizing the original anti-C5 function-blocking antibody, BB5.1, for species specificity, mode of action and interactions with C5.

Zelek WM, Menzies GE, Brancale A, Stockinger B, Morgan BP. Zelek WM, et al. Immunology. 2020 Oct;161(2):103-113. doi: 10.1111/imm.13228. Epub 2020 Jul 13. Immunology. 2020. PMID: 32557571 Free PMC article.

9

Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19.

Zelek WM, Cole J, Ponsford MJ, Harrison RA, Schroeder BE, Webb N, Jolles S, Fegan C, Morgan M, Wise MP, Morgan BP. Zelek WM, et al. Am J Respir Crit Care Med. 2020 Nov 1;202(9):1304-1308. doi: 10.1164/rccm.202007-2778LE. Am J Respir Crit Care Med. 2020. PMID: 32897730 Free PMC article. No abstract available.

10

Development of a high-throughput SARS-CoV-2 antibody testing pathway using dried blood spot specimens.

Moat SJ, Zelek WM, Carne E, Ponsford MJ, Bramhall K, Jones S, El-Shanawany T, Wise MP, Thomas A, George C, Fegan C, Steven R, Webb R, Weeks I, Morgan BP, Jolles S. Moat SJ, et al. Among authors: zelek wm. Ann Clin Biochem. 2021 Mar;58(2):123-131. doi: 10.1177/0004563220981106. Epub 2020 Dec 26. Ann Clin Biochem. 2021. PMID: 33269949 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page